Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P19 (suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 19) is a processed pseudogene located at chromosome 1q32.2 (positions 210,265,636-210,267,241, NCBI Gene ID: 100131961). This pseudogene derives from the ST13 gene, which encodes the Hsp70 interacting protein, but ST13P19 itself does *not* produce a functional protein. Like other processed pseudogenes, it likely formed via retrotransposition and lacks the ability to be translated into a protein. There is no evidence that it acts as a receptor, enzyme, or other typical therapeutic target. Some pseudogenes can play regulatory roles at the RNA level, but no functional or disease-related roles for ST13P19 have been reported in the current literature.
Not applicable (no drugs are known to target ST13P19)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 19 (ST13P19).